Hatteras Venture Advisors IV SBIC, LLC 13D and 13G filings for Clearside Biomedical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-21 4:30 pm Purchase |
2024-09-13 | 13D | Clearside Biomedical, Inc. CLSD |
Hatteras Venture Advisors IV SBIC, LLC | 313,641 0.400% |
313,641![]() (New Position) |
Filing |